Publications by authors named "Monica K Li"

9 Publications

  • Page 1 of 1

89% Vichy mineralizing water with hyaluronic acid is a well-tolerated adjunct treatment that helps restore skin barrier function in dry skin-related inflammatory dermatoses and post-procedure skin care: A Canadian study.

J Cosmet Dermatol 2021 Mar 31. Epub 2021 Mar 31.

Vichy Laboratoires, Montreal, Quebec, Canada.

Introduction: Minéral 89 (M89), comprised of 89% Vichy mineralizing water and hyaluronic acid, has been formulated to help strengthen and restore skin barrier.

Aim: Assess tolerance and efficacy of M89 in post-aesthetic procedures and dry skin-related facial dermatoses.

Method: Adults post-aesthetic procedure or presenting with inflammatory dermatoses (47 subjects; mean age 40.9 ± 13.2 years; any Fitzpatrick or skin phototype), applied M89 for 4 weeks, once or twice daily, as an adjuvant treatment. Information on clinical signs and subject-reported symptoms, skin characteristics, tolerance, and subject and investigator satisfaction were collected.

Results: Following 4 weeks of M89 use, significant decreases with complete resolution of erythema (27.6%), desquamation (29.8%), irritation (32%), and skin dehydration (35.8%), as compared to baseline signs and symptoms, were observed. Overall grading improvements for erythema (84.8%; p < 0.001), desquamation (91.7%; %; p < 0.003), irritation (91.7%; %; p < 0.015), and skin hydration (46.2%; p < 0.015) were noted. There was no significant improvement in papules and pustules. Evaluation of subjective signs demonstrated significant decreases in skin sensations such as burning (-73%; p < 0.0001), itching (-71%; p < 0.0001), stinging-tingling (-66.7%; p < 0.0001), as well as in skin dryness (-60%; p < 0.0001). M89 texture was rated very pleasant by 90% of patients. Investigators assessed M89 tolerance to be either good or very good (93%), and satisfactory or highly satisfactory impact on patient's skin (91.5%).

Conclusion: M89 is a highly tolerable adjuvant treatment that significantly improved clinical signs and symptoms related to a compromised skin barrier in various facial dermatoses and post-aesthetic procedures.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1111/jocd.14116DOI Listing
March 2021

Reply to: Cohen and Ross: "Laser-Induced Chrysiasis: A Unique Adverse Event Associated with Q-Switched Lasers".

Am J Clin Dermatol 2021 Mar 27;22(2):291. Epub 2021 Feb 27.

City Medical Aesthetics Center, Vancouver, BC, USA.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-021-00589-5DOI Listing
March 2021

Dermatologic Laser Side Effects and Complications: Prevention and Management.

Am J Clin Dermatol 2020 Oct;21(5):711-723

City Medical Aesthetics Center, Vancouver, BC, Canada.

The evolution of modern laser and light-based systems has mirrored the demand for clinically effective treatments and the need for safer technologies with reduced postoperative recovery, side effects, and complications. With each new generation of lasers, more selective tissue destruction can be achieved with reduced unwanted sequelae. Patient selection and preparation, operator technique, and expeditious recognition and management of post-treatment side effects are paramount in avoiding complications and patient dissatisfaction. An overview of important variables to consider for dermatologic laser treatments are presented in order to provide a framework to reduce the severity and duration of possible post-treatment side effects and complications.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-020-00530-2DOI Listing
October 2020

Dermatologic Laser Side Effects and Complications: Prevention and Management.

Am J Clin Dermatol 2020 Oct;21(5):711-723

City Medical Aesthetics Center, Vancouver, BC, Canada.

The evolution of modern laser and light-based systems has mirrored the demand for clinically effective treatments and the need for safer technologies with reduced postoperative recovery, side effects, and complications. With each new generation of lasers, more selective tissue destruction can be achieved with reduced unwanted sequelae. Patient selection and preparation, operator technique, and expeditious recognition and management of post-treatment side effects are paramount in avoiding complications and patient dissatisfaction. An overview of important variables to consider for dermatologic laser treatments are presented in order to provide a framework to reduce the severity and duration of possible post-treatment side effects and complications.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-020-00530-2DOI Listing
October 2020

Skin Surface pH

J Drugs Dermatol 2019 Dec;18(12):214

The role of skin surface pH, also referred to as “acid mantle,” was described more than 90 years ago and due to developing insights has now returned into focus.1
View Article and Find Full Text PDF

Download full-text PDF

Source
December 2019

Microneedling Treatment of Striae Distensae in Light and Dark Skin With Long-Term Follow-Up.

Dermatol Surg 2020 04;46(4):459-464

MKL Dermatology, Vancouver, British Columbia, Canada.

Background: Striae distensae have notoriously been difficult to treat due to their extensive involvement of nonfacial skin. Microneedling with its lack of thermal injury during microneedling treatment renders it a viable treatment option in darker skin tones and nonfacial regions due to the reduced risk of postinflammatory hyperpigmentation.

Objective: To describe the clinical results and side effects of microneedling in a series of 25 individuals with striae distensae.

Materials And Methods: Twenty-five consecutive adults (SPT I-V) with striae distensae involving the trunk and extremities were treated using a microneedling device. No additional treatments (topical or intralesional) were applied. Two assessors blinded to treatment protocol rated clinical improvement of striae on a 5-point scale. Side effects were monitored and tabulated.

Results: Patients received 1 to 3 consecutive monthly treatments. All striae improved at least 50% after an average of 1.8 treatments, and 28% of patients demonstrated more than 75% clinical improvement. Striae in thicker skin regions (e.g., buttocks/thighs) showed comparable clinical improvement than those in thinner skin areas (e.g., breasts) and did not require additional treatment sessions. Side effects were limited to transient erythema in all skin phototypes. No infections or dyspigmentation were observed.

Conclusion: The clinical results obtained in this study support the safe and effective treatment of striae distensae with microneedling in light and dark skin tones in various body locations. Standardization of treatment protocols are anticipated with further (ongoing) studies.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000002081DOI Listing
April 2020

Use of 3-Dimensional Imaging in Submental Fat Reduction After Cryolipolysis.

Dermatol Surg 2018 Jun;44(6):889-892

McDaniel Institute of Anti-Aging Research, Virginia Beach, Virginia Canfield Scientific, Inc., Parsippany, New Jersey McDaniel Institute of Anti-Aging Research, Virginia Beach, Virginia, Hampton University Skin of Color Research Institute, School of Science, Hampton University, Hampton, Virginia, Department of Biological Sciences, Old Dominion University, Norfolk, Virginia.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000001343DOI Listing
June 2018

Use of 3-Dimensional Imaging in Submental Fat Reduction After Deoxycholic Acid Injection.

Dermatol Surg 2018 Apr;44(4):599-602

McDaniel Institute of Anti-Aging Research, Virginia Beach, Virginia McDaniel Institute of Anti-Aging Research, Virginia Beach, Virginia Hampton University Skin of Color Research Institute, School of Science, Hampton University, Hampton, Virginia, Department of Biological Sciences, Old Dominion University, Norfolk, Virginia Canfield Scientific, Inc., Parsippany, New Jersey.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1097/DSS.0000000000001342DOI Listing
April 2018

Laser Therapy for an Acquired Glomuvenous Malformation (Glomus Tumour): A Nonsurgical Approach.

J Cutan Med Surg 2016 Jan 15;20(1):80-3. Epub 2015 Jul 15.

Division of Anatomical Pathology (Dermatopathology), Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.

Background: Glomuvenous malformations (GVMs) (previously known as glomus tumours) are uncommon, benign, vascular neoplasms. Current treatments include surgical excision and sclerotherapy, often with high recurrence rates and poor cosmetic results.

Objective: We sought to use a nonsurgical approach for treatment of a GVM.

Methods: We present a patient with an acquired, biopsy-proven GVM of the heel unamenable to surgical excision, treated with a long pulsed 1064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser.

Results: Excellent cosmesis and long-term remission were achieved after several treatment sessions.

Conclusion: Our experience provides further evidence to support the safety and effectiveness of the 1064-nm Nd:YAG laser in the management of large and surgically challenging GVMs.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1177/1203475415596121DOI Listing
January 2016